Research Article

Whole Body Bone Tissue and Cardiovascular Risk in Rheumatoid Arthritis

Table 5

wbDXA bone indices according to cardiovascular morbidity ( ).

Nonobese
( )
Obese
( )
Nfpg
( )
HFPG
( )

wbBTD (g/cm2)0.771 (0.091)0.795 (0.096)ns0.762 (0.095)0.798 (0.088)0.022
wbBTM (kg)1.46 (0.21)1.63 (0.30)<0.0011.46 (0.22)1.57 (0.28)0.012
(sd)−1.06 (0.84)−0.65 (0.99)0.011−1.16 (0.84)−0.65 (0.92)0.001
(sd)−1.4 (0.99)−1.1 (1)ns−1.51 (1)−1.10 (0.9)0.017
BTP (%)2.9 (0.3)2.5 (0.3)<0.0112.9 (0.3)2.5 (0.3)ns

No IS
( )
With IS
( )
No IHD
( )
With IHD
( )

BTP (%)2.8 (0.4)2.6 (0.4)0.0182.8 (0.4)2.6 (0.2)0.004
BTDlumbar (g/cm2)0.907 (0.164)0.838 (0.205)0.0300.878 (0.186)0.858 (0.196)ns
Tlumbar (sd)−0.28 (1.2)−0.79 (1.5)0.030−0.49 (1.3)−0.63 (1.4)ns

No MS
( )
With MS
( )
No DM
( )
With DM
( )

BTP (%)2.9 (0.4)2.6 (0.3)<0.0012.8 (0.4)2.4 (0.3)0.001

No DL
( )
With DL
( )
No AHT
( )
With AHT
( )

BTP (%)2.9 (0.4)2.7 (0.3)0.0042.9 (0.4)2.6 (0.3)<0.001

Sd: standard deviation; ns: not significant; n/Hfpt: normal/high plasma fasting glucose; IS: inflammatory syndrome; DL: dyslipidemia; MS: metabolic syndrome.